A theme involving the reorganization of the pharmaceutical manufacturing business into the healthcare product development business and the prescription pharmacy business into the community healthcare and nursing care support business in line with the new medium-term management plan, as well as the addition of a contract specialty pharmaceutical distribution business, changing the reporting segments from 4 to 5. This includes introducing business management classifications for the transition to a health-creation business group.